Rest Of Europe Pen Needles Market (2024-2029)
The Rest Of Europe Pen Needles Market was valued at $298.6 Million in 2024 and projected to reach to $535.1 Million by 2029, representing a compound annual growth rate of 10.2%. Rest of Europe's pen needles market is positioned for sustained expansion through 2029, supported by demographic shifts toward older populations with higher diabetes incidence rates.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Rest Of Europe Pen Needles Market Trends and Insights
- Asia Pacific's 10.2% compound annual growth rate outpaces global trends, driven by rising diabetes prevalence, increasing adoption of injectable therapies, and expanding healthcare infrastructure across the region.
- The market in Asia Pacific benefits from growing patient awareness, improved access to diabetes management devices, and supportive government health initiatives. Asia Pacific's pen needles market is characterized by strong demand from both developed and emerging economies within the region.
- Key drivers include the region's large diabetic population, rising disposable incomes, and accelerating digital health adoption.
- Asia Pacific manufacturers are increasingly focusing on product innovation, safety features, and cost-effective solutions to capture market share.
- The forecast period through 2029 reflects Asia Pacific's potential as a high-growth market, supported by demographic shifts and healthcare modernization efforts across the region..
Key Market Statistics
- CAGR (2024-2029) 10.2% CAGR
- Market Size, 2024 ~USD 298.6 Million
- Forecast, 2029 ~USD 535.1 Million
- Country Rest Of Europe
Rest Of Europe Pen Needles Market Overview
Market Valuation :
Rest of Europe's pen needles market is valued at USD 298.6 million in 2024, demonstrating significant market maturity and established healthcare infrastructure across the region.
Projected Growth :
The market is forecasted to reach USD 535.1 million by 2029, representing a robust 10.2% CAGR that exceeds the global average of 9.2%, indicating accelerating regional demand.
Regional Performance :
Rest of Europe's growth trajectory outpaces global trends, driven by aging populations, increasing diabetes prevalence, and widespread adoption of self-injection therapies across smaller European markets.
Healthcare Expansion :
Enhanced reimbursement policies, improved access to injectable diabetes treatments, and growing awareness of pen needle safety standards are propelling market expansion throughout the region.
Rest Of Europe Pen Needles Market Dynamics
- The region's established healthcare systems and increasing preference for convenient self-administration devices are driving consistent adoption across both primary and secondary care settings.
- Regulatory harmonization and improved reimbursement frameworks are facilitating market penetration in smaller European nations.
- The 10.2% CAGR reflects growing investment in diabetes management infrastructure and rising patient awareness of injection safety and comfort.
- Market consolidation among regional distributors and expanding product portfolios tailored to European preferences will further accelerate growth, positioning Rest of Europe as a key contributor to the broader European pen needles market expansion..
Related Ecosystem
Drug Delivery Devices
- Disposable Autoinjectors
- Reusable Autoinjectors
- Insulin Pumps
- Pen Injectors
- Transdermal Patches
- Novo nordisk a/s
- Becton, Dickinson and Company
- Terumo Corporation
- Medtronic plc
- Nipro Corporation
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- Asia Pacific pen needles market is valued at USD 298.6 million in 2024 and expected to reach USD 535.1 million by 2029, representing a 10.2% CAGR.
- Asia Pacific's growth rate exceeds global averages, driven by high diabetes incidence and expanding healthcare access across the region.
- Asia Pacific markets are increasingly adopting advanced needle technologies and safety-engineered devices to improve patient outcomes.
- Asia Pacific's emerging economies present significant untapped opportunities for market expansion through improved distribution and affordability initiatives.
Pen Needles Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | SAFETY PEN NEEDLES (Type) |
| Forecast Period | 2024–2029 |
| Growth Rate | CAGR of 9.2% from 2024 to 2029 |
| Largest Segment | STANDARD PEN NEEDLES (Type) |
| Market Size Base Year (Billions) | ~USD 1.82 (2024) |
| Revenue Forecast (Billions) | ~USD 3.08 (2029) |
| Segments Covered | Type, Length, Application, Mode Of Purchase, Care Setting |
Rest Of Europe Pen Needles Market Report Segmentation
5 segment dimensions are covered across the global market.
By Type
- Safety Pen Needles
- Standard Pen Needles
By Length
- 10Mm
- 12Mm
- 4Mm
- 5Mm
- 6Mm
- 8Mm
By Application
- Glp-1 Therapy
- Growth Hormone Therapy
- Insulin Therapy
- Osteoporosis
- Other Applications
By Mode Of Purchase
- Online Purchase
- Otc Purchase
- Other Modes Of Purchase
- Prescription-Based Purchase
By Care Setting
- Home Care Settings
- Hospitals & Clinics
- Hospitals And Clinics
- Other End Users
Target Audience
- Medical Device Manufacturers : Manufacturers need Rest of Europe-specific market data to assess regional demand, optimize product portfolios, and allocate R&D resources toward high-growth European markets with distinct regulatory requirements.
- Healthcare Distributors & Wholesalers : Distributors require detailed market forecasts and regional growth metrics to plan inventory, negotiate supplier contracts, and identify expansion opportunities across Rest of Europe's fragmented healthcare systems.
- Pharmaceutical & Diabetes Care Companies : Pharma companies need regional market intelligence to align injectable therapy launches, support healthcare provider partnerships, and develop patient education programs tailored to Rest of Europe's diverse markets.
- Healthcare Investors & Private Equity : Investors require validated market sizing and growth projections for Rest of Europe to evaluate acquisition targets, assess portfolio company performance, and identify emerging opportunities in regional healthcare.
- Healthcare Policy & Regulatory Bodies : Policymakers and regulators need market data to understand adoption trends, assess reimbursement policies, and develop evidence-based guidelines for injectable device safety and accessibility across Rest of Europe.
Key Companies in the Rest Of Europe Pen Needles Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KINDRED HEALTHCARE INC. | United States | Private Company | Injectable and infusion-based delivery in LTAC hospitals,Oral drug administration in inpatient rehabilitation facilities,Contract rehabilitation and outpatient-related drug administration support, |
| ATS AUTOMATION TOOLING SYSTEMS INC | Canada | Public Company | Turnkey automated manufacturing and assembly systems,Lifecycle services and digital/connected factory solutions,Contract manufacturing and value-added integration, |
| ALLERGAN PLC | Ireland | Private Company | Medical Aesthetics & Dermatology,Eye Care,Neuroscience & CNS, |
| CONSORT MEDICAL | United Kingdom | Private Company | Inhalation delivery devices,Injectable and autoinjector devices,Nasal and other specialty devices, |
| HENRY SCHEIN | United States | Public Company | Global Distribution & Value-Added Services,Global Specialty Products,Global Technology, |
| EMBECTA CORP. | United States | Public Company | Pen needles,Syringes,Safety injection devices, |
| NOVO NORDISK A/S | Denmark | Public Company | GLP-1 for Diabetes (injectable and oral),Obesity Care (GLP-1, including Wegovy pill),Insulin and Smart Pens (NovoPen 6, Echo Plus, needles), |
| YPSOMED | Switzerland | Public Company | Pen injectors,Auto-injectors,Wearable injectors and patch pumps, |
| TERUMO CORPORATION | Japan | Public Company | Cardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company, |
| NIPRO | Japan | Public Company | Dialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products,Pharmaceutical-related (generics, kits, CDMO for injectables and oral drugs), |
| ARKRAY, INC. | Japan | Private Company | Diabetes testing & blood glucose monitoring,Urinalysis,Immunodiagnostics, |
| HTL-STREFA | Poland | Private Company | Safety lancets for professional capillary sampling,Personal lancets for home blood glucose monitoring,Pen needles for diabetes therapy, |
| BERPU MEDICAL TECHNOLOGY CO., LTD. | China | Private Company | Regular insulin pen needles,Safety insulin pen needles and pens,Hypodermic and hypo-dermal needles, |
KINDRED HEALTHCARE INC.
Kindred Healthcare Inc. is a United States-based private company founded in 1985 that operates with 64,200 employees. The company provides healthcare services and related solutions across the United States.
ATS AUTOMATION TOOLING SYSTEMS INC
ATS Automation Tooling Systems Inc. is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.
ALLERGAN PLC
Allergan PLC is an Ireland-based private company founded in 1983 with 17,400 employees. The company operates in the pharmaceutical and medical aesthetics sectors.
CONSORT MEDICAL
Consort Medical is a United Kingdom-based private company founded in 1938 with 2,000 employees. The company provides medical device and pharmaceutical delivery solutions.
HENRY SCHEIN
Henry Schein is a United States-based public company founded in 1932 with 25,000 employees. The company is a distributor of healthcare products and services to medical, dental, and veterinary professionals.
EMBECTA CORP.
Embecta Corp. is a United States-based public company founded in 1924 with 1,850 employees. The company manufactures and distributes diabetes care and medical devices.
NOVO NORDISK A/S
Novo Nordisk A/S is a Denmark-based public company founded in 1923 with 67,900 employees. The company is a global pharmaceutical company specializing in diabetes, obesity, and other chronic diseases.
YPSOMED
Ypsomed is a Switzerland-based public company founded in 1984 with 2,025 employees. The company develops and manufactures injection and infusion systems for diabetes and other therapeutic areas.
TERUMO CORPORATION
Terumo Corporation is a Japan-based public company founded in 1921 with 30,591 employees. The company manufactures and distributes medical devices, blood products, and pharmaceutical solutions globally.
NIPRO
Nipro is a Japan-based public company founded in 1947 with 38,593 employees. The company manufactures and supplies medical devices, pharmaceuticals, and healthcare products worldwide.
ARKRAY, INC.
Arkray, Inc. is a Japan-based private company founded in 1960 with 566 employees. The company manufactures diagnostic and medical devices for healthcare applications.
HTL-STREFA
HTL-Strefa is a Poland-based private company founded in 2000. The company manufactures medical devices and related healthcare products.
BERPU MEDICAL TECHNOLOGY CO., LTD.
Berpu Medical Technology Co., Ltd. is a China-based private company founded in 2000. The company manufactures medical devices and related healthcare solutions.
Reasons to Buy this Report
- Regional Market Sizing : Obtain precise valuation data for Rest of Europe's pen needles market with verified 2024 baseline (USD 298.6M) and 2029 forecasts, enabling accurate regional business planning and investment decisions.
- Growth Trajectory Analysis : Understand the 10.2% CAGR dynamics specific to Rest of Europe, outpacing global averages, to identify expansion opportunities and competitive advantages in smaller European markets.
- Market Entry Strategy : Leverage region-specific insights on healthcare infrastructure, reimbursement policies, and patient adoption patterns to develop targeted market entry and localization strategies for Rest of Europe.
- Competitive Positioning : Benchmark your portfolio against regional market trends and identify gaps in product offerings, distribution channels, and customer segments unique to Rest of Europe's healthcare landscape.
- Investment Justification : Present stakeholders with data-driven evidence of Rest of Europe's strong growth potential and market maturity to secure funding for regional expansion, partnerships, and product development initiatives.
Frequently asked questions
What is the current market size of pen needles in Asia Pacific?
The Asia Pacific pen needles market was valued at USD 298.6 million in 2024 and is projected to grow to USD 535.1 million by 2029.
What is the expected growth rate for Asia Pacific pen needles market?
Asia Pacific's pen needles market is expected to grow at a compound annual growth rate (CAGR) of 10.2% from 2024 to 2029.
What factors are driving growth in the Asia Pacific pen needles market?
Key growth drivers in Asia Pacific include rising diabetes prevalence, increasing adoption of injectable therapies, expanding healthcare infrastructure, growing patient awareness, and supportive government health initiatives.
Which countries in Asia Pacific represent the largest market opportunities?
Asia Pacific's largest opportunities exist in developed markets like Japan and Australia, as well as high-growth emerging economies such as China, India, and Southeast Asian nations with expanding middle-class populations.
How does Asia Pacific's growth compare to the global pen needles market?
Asia Pacific's 10.2% CAGR outpaces the global market growth rate of 9.2%, positioning the region as a high-growth market with significant expansion potential through 2029.
RESEARCH METHODOLOGY
This research study involved the extensive use of both primary and secondary sources. It involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.
Secondary Research
This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, white papers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the pen needles market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply side and demand side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the pen needles market. Primary sources from the demand side included hospitals, clinics, researchers, lab technicians, purchase managers etc, and stakeholders in corporate & government bodies.
A breakdown of the primary respondents for pen needles market (supply side) market is provided below:
Note 1: Companies are classified into tiers based on their total revenue. As of 2023: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.
Note 2: C-level executives include CEOs, COOs, CTOs, and VPs.
Note 3: Other primaries include sales managers, marketing managers, and product managers.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The market size for pen needles market was calculated using data from four different sources, as will be discussed below. Each technique concluded and a weighted average of the four ways was calculated based on the number of assumptions each approach made. The market size for pen needles market was calculated using data from three distinct sources, as will be discussed below:
Data Triangulation
The entire market was split up into five segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at the precise statistics for all segments.
Approach to derive the market size and estimate market growth.
Using secondary data from both paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of pen needles. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.
Market Definition
A pen needle is a hollow needle entrenched in a plastic hub and attached to injectable pens. Pen needles are available in a wide range of lengths and diameters and can be used by healthcare professionals and patients to deliver injectable medications into the patient’s body. Pen needles are electro-polished for smooth, thin, and fine-point tips and provide comfort and ease in penetration; they serve as an alternative drug delivery technique to the traditional method of injecting drugs.
Stakeholders
- Manufacturers of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies
- Original equipment manufacturing companies
- Suppliers and distributors of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies
- Healthcare service providers
- Teaching hospitals and academic medical centers
- Health insurance players
- Government bodies/municipal corporations
- Regulatory bodies
- Business research and consulting service providers
- Authorities framing reimbursement policies for pen needles
- Venture capitalists
- Market research and consulting firms
Report Objectives
- To define, describe, and forecast the pen needles market based on type, length, application, mode of purchase, setting and region.
- To provide detailed information about the major factors influencing the market growth (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall pen needles market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the pen needles market in North America, Europe, the Asia Pacific, Latin America, Middle East & Africa and GCC Countries
- To profile the key players and comprehensively analyze their market shares and core competencies in the pen needles market
- To track and analyze competitive developments such as partnerships, expansions, acquisitions, collaborations, product launches, agreements, and other developments in the pen needles market
- To benchmark players within the pen needles market using the Company Evaluation Quadrant framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings.
Get the Full Pen Needles Market Report
Full forecast, segment splits, and company analysis for all Pen Needles Market.
- Canada Pen Needles Market
- US Pen Needles Market
- Germany Pen Needles Market
- UK Pen Needles Market
- France Pen Needles Market
- Italy Pen Needles Market
- Spain Pen Needles Market
- Japan Pen Needles Market
- China Pen Needles Market
- India Pen Needles Market
- South Korea Pen Needles Market
- Brazil Pen Needles Market
- Mexico Pen Needles Market
- Argentina Pen Needles Market
- GCC Countries Pen Needles Market
- Rest Of Asia Pacific Pen Needles Market
- Southeast Asia Pen Needles Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
